Karyopharm Therapeutics
KPTI
KPTI
149 hedge funds and large institutions have $303M invested in Karyopharm Therapeutics in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 58 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+10
Holders Change %
+7.19%
% of All Funds
2.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
39
Reduced
58
Closed
13
Calls
$4.7M
Puts
$1.92M
Net Calls
+$2.77M
Net Calls Change
-$5.1M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Dimensional Fund Advisors
Austin,
Texas
| – | -$174K | -1,571 | Closed |
|
|
BAM
152
Blueshift Asset Management
Red Bank,
New Jersey
| – | -$164K | -1,482 | Closed |
|
|
BC
153
BIT Capital
Berlin,
Germany
| – | -$95.8K | -867 | Closed |
|
|
AWA
154
Aaron Wealth Advisors
Chicago,
Illinois
| – | -$385K | -189 | Closed |
|
|
FFWM
155
Future Financial Wealth Management
Cincinnati,
Ohio
| – | -$7K | -60 | Closed |
|
|
IC
156
Ikarian Capital
Dallas,
Texas
| – | -$6K | -55 | Closed |
|
|
JG
157
Jefferies Group
New York
| – | -$737 | -7 | Closed |
|
|
APA
158
American Portfolios Advisors
Holbrook,
New York
| – | -$612 | -6 | Closed |
|